Daniela Piras - Concepedia

Author

Daniela Piras

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

D Piras, D. Piras, Daniela A. Piras, Daniela Antonella Piras, Daniela Piras, Piras, Daniela Antonella, R Cavallo, Rossella Cavallo, Silvano PIFFER

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Fondazione IRCCS Istituto Nazionale dei Tumori University of Sassari Centro di Riferimento Oncologico University of Parma

About

Daniela Piras is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	514
2	Natural Sciences	5	5	217
3	Engineering	2	2	89
4	Biochemistry	2	2	126
5	Public Health	1	1	95

Daniela Piras

Publications

Citations

H-Index

Page 1

	Year	Citations
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study Laura Botta, Gemma Gatta, Riccardo Capocaccia, The Lancet Oncology Cure Fraction EstimatesCancer EpidemiologyChildhood CancerMedicineCancer Management	2022	167
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer David N. Brown, Irene Caffa, Gabriella Cirmena, Scientific Reports	2016	145
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study Roberta De Angelis, Elena Demuru, Paolo Baili, The Lancet Oncology Disease DurationEpidemiologyPopulation-based StudyCancer EpidemiologyCancer Risk	2024	95
A New Essential Hypertension Susceptibility Locus on Chromosome 2p24-p25, Detected by Genomewide Search Andrea Angius, Enrico Petretto, Giovanni Battista Maestrale, The American Journal of Human Genetics Genetic DeterminantGenetic DisorderGeneticsGenetic EpidemiologyHuman Polymorphism	2002	76
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity G. ROMA, Giancarlo Grossi, Mario Di Braccio, European Journal of Medicinal Chemistry Medicinal ChemistryDerivative (Chemistry)BiochemistryNatural SciencesMedicine	2007	72
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries Naomi Ssenyonga, Charles Stiller, Kayo Nakata, The Lancet Child & Adolescent Health	2022	65
Solid-Phase Synthesis of Conformationally Constrained Peptidomimetics Based on a 3,6-Disubstituted-1,4-diazepan-2,5-dione Core L. R. LAMPARIELLO, Daniela Piras, Manuela Rodriquez, The Journal of Organic Chemistry Combinatorial ChemistryBioorganic ChemistryEngineeringOrganic ChemistryConformationally Constrained Peptidomimetics	2003	54
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity G. ROMA, Mario Di Braccio, Giancarlo Grossi, European Journal of Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryMedicineNatural SciencesAcute Gastrolesivity	2009	42
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives Martina Chittani, Roberta Zaninello, Chiara Lanzani, Journal of Hypertension	2015	38
Synthesis and In Vitro Antiplatelet Activity of New 4-(1-Piperazinyl)coumarin Derivatives. Human Platelet Phosphodiesterase 3 Inhibitory Properties of the Two Most Effective Compounds Described and Molecular Modeling Study on Their Interactions with Phosphodiesterase 3A Catalytic Site G. ROMA, Mario Di Braccio, Giancarlo Grossi, Journal of Medicinal Chemistry	2007	38

Page 1